V. G. ValcourP. SithinamsuwanS. NidhinandanaS. ThitivichianlertS. Ratto-KimW. ApateerapongB. T. ShiramizuM. S. DeSouzaS. T. ChitpatimaG. WattT. ChuenchitraK. R. RobertsonR. H. PaulJ. C. McArthurJ. H. KimC. M. ShikumaUniversity of Hawaii at Manoa John A. Burns School of MedicineThe University of North Carolina at Chapel HillUniversity of Missouri-St. LouisJohns Hopkins UniversityPhramongkutklao HospitalPhramongkutklao HospitalArmed Forces Research Institute of the Medical SciencesMahidol UniversityArmed Forces Research Institute of Medical Sciences, ThailandLeahi Hospital2018-08-242018-08-242007-02-01Neurology. Vol.68, No.7 (2007), 525-527002838782-s2.0-33847011782https://repository.li.mahidol.ac.th/handle/20.500.14594/25020HIV-associated dementia (HAD) is not firmly established in patients with circulating recombinant form (CRF) 01_AE HIV-1. In this study, we compared neuropsychological performance among 15 Thai individuals with HAD, 15 Thai individuals without HAD, and 30 HIV-negative control subjects. HIV-1 participants were highly active anti-retroviral therapy naive and matched by age, education, and CD4 count. Neuropsychological testing abnormalities were identified in most cognitive domains among HAD vs HIV-negative participants, confirming the presence of HAD in CRF01_AE. ©2007AAN Enterprises, Inc.Mahidol UniversityMedicineArticleSCOPUS10.1212/01.wnl.0000253196.78193.c7